Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSEPH M CAPORUSSO

Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery

NPI
1528062213
CMS profile
68739
Location
MCALLEN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$46,781.10

106 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Honoraria $35,950.00 19
Travel and Lodging $10,114.44 73
Food and Beverage $716.66 14

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
ORGANOGENESIS INC. $46,618.42 100
TissueTech, Inc. $106.74 1
Amniox Medical, Inc. $42.05 3
Aroa Biosurgery Incorporated $13.89 2

Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSEPH M CAPORUSSO

NPI 1528062213 · CMS profile ID 68739

Podiatric Medicine & Surgery Service Providers / Podiatrist / Foot & Ankle Surgery

MCALLEN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1528062213?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSEPH M CAPORUSSO, NPI 1528062213, CMS profile ID 68739. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1528062213?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JOSEPH M CAPORUSSO, NPI 1528062213, CMS profile ID 68739. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1528062213?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JOSEPH M CAPORUSSO, NPI 1528062213, CMS profile ID 68739, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1528062213?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

106 matching records · $46,781.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 106 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 106.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637779 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637789 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637805 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861793 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861801 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861817 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861825 CMS
ORGANOGENESIS INC. $12.0011/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861827 CMS
TissueTech, Inc. $106.7410/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751940563 CMS
Aroa Biosurgery Incorporated $6.8910/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 717232857 CMS
ORGANOGENESIS INC. $829.2010/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637795 CMS
ORGANOGENESIS INC. $134.6810/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637807 CMS
ORGANOGENESIS INC. $60.0010/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637837 CMS
ORGANOGENESIS INC. $60.0010/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861805 CMS
ORGANOGENESIS INC. $829.2010/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861809 CMS
ORGANOGENESIS INC. $134.6810/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861855 CMS
ORGANOGENESIS INC. $3,000.0010/01/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861867 CMS
ORGANOGENESIS INC. $395.2008/13/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637761 CMS
ORGANOGENESIS INC. $3,000.0008/13/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861845 CMS
ORGANOGENESIS INC. $395.2008/13/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861853 CMS
ORGANOGENESIS INC. $45.0008/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637765 CMS
ORGANOGENESIS INC. $45.0008/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861835 CMS
ORGANOGENESIS INC. $1,950.0006/18/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861843 CMS
ORGANOGENESIS INC. $1,000.0006/02/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861859 CMS
Amniox Medical, Inc. $6.5905/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737141107 CMS
Amniox Medical, Inc. $12.8005/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737141115 CMS
Amniox Medical, Inc. $22.6605/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737141099 CMS
Aroa Biosurgery Incorporated $7.0004/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 717232861 CMS
ORGANOGENESIS INC. $1,200.0003/26/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861765 CMS
ORGANOGENESIS INC. $1,200.0003/24/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861851 CMS
ORGANOGENESIS INC. $1,200.0003/16/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861811 CMS
ORGANOGENESIS INC. $1,200.0003/16/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861857 CMS
ORGANOGENESIS INC. $1,950.0003/16/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861873 CMS
ORGANOGENESIS INC. $1,950.0003/10/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861799 CMS
ORGANOGENESIS INC. $129.8502/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637759 CMS
ORGANOGENESIS INC. $3,000.0002/24/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861849 CMS
ORGANOGENESIS INC. $525.7502/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637775 CMS
ORGANOGENESIS INC. $125.0002/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637783 CMS
ORGANOGENESIS INC. $245.2002/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637785 CMS
ORGANOGENESIS INC. $245.2002/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637801 CMS
ORGANOGENESIS INC. $123.2602/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637803 CMS
ORGANOGENESIS INC. $123.2702/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637817 CMS
ORGANOGENESIS INC. $20.8102/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750637825 CMS
ORGANOGENESIS INC. $525.7502/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861767 CMS
ORGANOGENESIS INC. $1,200.0002/10/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861787 CMS
ORGANOGENESIS INC. $123.2702/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861789 CMS
ORGANOGENESIS INC. $3,000.0002/10/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861795 CMS
ORGANOGENESIS INC. $123.2602/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861815 CMS
ORGANOGENESIS INC. $245.2002/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861829 CMS
ORGANOGENESIS INC. $245.2002/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751861837 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $57,561.11 110
PY2020 $46,781.10 106
PY2021 $81,267.70 158
PY2022 $82,424.00 103
PY2023 $18,623.87 19
PY2024 $1,444.55 3
PY2025 $1,122.91 7

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,348.61 8
PY2025 Principal investigator $293,471.68 50
PY2024 Principal investigator $1,220,757.69 52
PY2023 Recipient $5,700.50 21
PY2023 Principal investigator $3,316,555.50 82
PY2022 Principal investigator $115,270.45 22
PY2021 Recipient $2,000.00 1
PY2021 Principal investigator $321,041.33 17
PY2020 Recipient $163,112.50 16
PY2020 Principal investigator $233,999.20 21
PY2019 Recipient $101,401.61 11
PY2019 Principal investigator $168,937.50 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

58 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Convatec Inc. $19,600.00 12/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
CNAP DFU (WC-24-447) No dispute reported 06/30/2026 1251656873
Principal investigator 1 Organogenesis Inc. $961.20 11/30/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242005095
Principal investigator 1 Organogenesis Inc. $6,549.79 10/20/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004622
Principal investigator 1 GlaxoSmithKline, LLC. $7,207.72 10/15/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192168158
Principal investigator 1 Organogenesis Inc. $4,371.20 09/30/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004489
Principal investigator 1 Organogenesis Inc. $2,600.00 09/30/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004495
Recipient Regeneron Pharmaceuticals, Inc. $284.80 09/19/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116049
Recipient Regeneron Pharmaceuticals, Inc. $150.03 09/19/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116051
Recipient Regeneron Pharmaceuticals, Inc. $70.93 09/19/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116053
Recipient Regeneron Pharmaceuticals, Inc. $40.92 09/19/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116055
Recipient Regeneron Pharmaceuticals, Inc. $95.48 09/19/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116057
Recipient Regeneron Pharmaceuticals, Inc. $40.92 09/19/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116059
Principal investigator 1 Organogenesis Inc. $7,181.60 08/31/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004245
Principal investigator 1 Organogenesis Inc. $16,917.76 08/31/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004250
Principal investigator 1 GlaxoSmithKline, LLC. $300.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192104172
Principal investigator 1 GlaxoSmithKline, LLC. $1,300.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164419
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164434
Principal investigator 1 GlaxoSmithKline, LLC. $750.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164451
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165008
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165015
Principal investigator 1 GlaxoSmithKline, LLC. $1,500.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165028
Principal investigator 1 GlaxoSmithKline, LLC. $950.00 08/18/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192168151
Recipient Regeneron Pharmaceuticals, Inc. $456.66 08/12/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116045
Recipient Regeneron Pharmaceuticals, Inc. $208.87 08/12/2025 Covered Recipient Physician A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) No dispute reported 06/30/2026 1184116047
Principal investigator 1 Organogenesis Inc. $20,327.52 07/31/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242003955
Principal investigator 1 Tris Pharma Inc $31,022.56 07/01/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879012
Principal investigator 1 Organogenesis Inc. $5,632.40 06/30/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242003671
Principal investigator 1 Organogenesis Inc. $5.72 06/30/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242003677
Principal investigator 1 Tris Pharma Inc $15,531.97 06/09/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879010
Principal investigator 1 BIOTISSUE HOLDINGS INC. $250.00 06/06/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS, LLC.
TTAX01-CR006 No dispute reported 06/30/2026 1246209415
Principal investigator 1 Organogenesis Inc. $11,739.00 05/31/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242003372
Principal investigator 1 BIOTISSUE HOLDINGS INC. $416.00 05/09/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS, LLC.
TTAX01-CR006 No dispute reported 06/30/2026 1246209413
Principal investigator 1 Organogenesis Inc. $11,014.00 04/30/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242002925
Principal investigator 1 Tris Pharma Inc $3,503.41 04/05/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879008
Principal investigator 1 Organogenesis Inc. $225.00 03/31/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242002356
Principal investigator 1 Tris Pharma Inc $1,200.00 03/21/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879006
Principal investigator 1 GlaxoSmithKline, LLC. $300.00 03/13/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165036
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 02/27/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165012
Principal investigator 1 GlaxoSmithKline, LLC. $300.00 02/26/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164447
Principal investigator 1 GlaxoSmithKline, LLC. $120.00 02/24/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165004
Principal investigator 1 GlaxoSmithKline, LLC. $1,744.20 02/10/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192104179
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192104185
Principal investigator 1 GlaxoSmithKline, LLC. $120.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192104192
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164415
Principal investigator 1 GlaxoSmithKline, LLC. $120.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164424
Principal investigator 1 GlaxoSmithKline, LLC. $120.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164429
Principal investigator 1 GlaxoSmithKline, LLC. $240.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164438
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165024
Principal investigator 1 GlaxoSmithKline, LLC. $420.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165032
Principal investigator 1 GlaxoSmithKline, LLC. $180.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192168145
Principal investigator 1 GlaxoSmithKline, LLC. $120.00 02/04/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192168153
Principal investigator 1 Tris Pharma Inc $1,600.00 01/29/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879004
Principal investigator 1 GlaxoSmithKline, LLC. $60.75 01/28/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192164443
Principal investigator 1 GlaxoSmithKline, LLC. $60.00 01/28/2025 Non-covered Recipient Entity
FUTURO CLINICAL TRIALS LLC
A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STU No dispute reported 06/30/2026 1192165020
Principal investigator 1 Tris Pharma Inc $107,583.43 01/23/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879000
Principal investigator 1 Tris Pharma Inc $7,041.10 01/23/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199879002
Principal investigator 1 Tris Pharma Inc $800.00 01/09/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199878996
Principal investigator 1 Tris Pharma Inc $125.35 01/09/2025 Non-covered Recipient Entity
Futuro Clinical Trials, LLC
TRIPHA TRN-228-302_Bunion_P3 No dispute reported 06/30/2026 1199878998